SCHEMBL24257549

SCHEMBL24257549

CCNC(=O)c1nc(C)cc(Cc2ccc(F)cc2)c1O

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ EGLN1 Q9GZT9 8/20 0.51
▸ ALDH1A1 P00352 1/20 0.43
▸ BRD4 O60885 1/20 0.43
▸ LMNA P02545 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ CES2 O00748 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ CNR2 P34972 1/20 0.38
▸ GPR55 Q9Y2T6 1/20 0.38
▸ FPR1 P21462 1/20 0.37
▸ GRIN1 Q05586 1/20 0.37
▸ GRIN2A Q12879 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257458 0.88 EGLN1 (0.67) EGLN1ALDH1A1
SCHEMBL30452505 0.87 EGLN1 (0.51) EGLN1ALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL26260056 0.87 EGLN1 (0.51) EGLN1ALDH1A1HPGDHSD17B10SMN1; SMN2
Formic Acid SCHEMBL30453300 0.84 EGLN1 (0.62) EGLN1ALDH1A1
SCHEMBL24257783 0.83 EGLN1 (0.44) EGLN1ALDH1A1CNR2GPR55HTT
SCHEMBL30453338 0.83 EGLN1 (0.44) EGLN1ALDH1A1CNR2GPR55HTT
SCHEMBL24257546 0.82 RNASEH1 (0.45) EGLN1ALDH1A1HPGDCES2CNR2
SCHEMBL30452522 0.82 RNASEH1 (0.45) EGLN1ALDH1A1HPGDCES2CNR2
SCHEMBL26567285 0.70 LMNA (0.55) ALDH1A1BRD4LMNAHPGDSMN1; SMN2
SCHEMBL26259639 0.69 EGLN1 (0.52) EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022036188-A1 PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE AKEBIA THERAPEUTICS, INC. (US) 2022-02-17 — — WO disclosed
Send feedback